Sep 2024 - Global pharmaceutical company Amneal Pharmaceuticals, Inc., and clinical-stage biopharmaceutical company Metsera, Inc., are accelerating next-generation medicines for obesity and metabolic diseases by joining forces with a portfolio of new weight loss medicines on efficient development and large-scale supply worldwide
South Korea and Australia approved local or imported GLP-1s but apply stringent BMI thresholds for publicly funded access, tempering early uptake
Communication with Healthcare Providers Before starting both medications, patients should discuss their full medical history with their healthcare provider
Wegovy is only administered in the abdomen, thigh, or upper armnever in the face or forehead
Lilly isnt changing the price of higher doses, which are sold for $499 a month